TADOGLEN 100mg/25mg/200mg film-coated tablets GLENMARK
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Find medicines for human use by name or active substance.
Browse by initial
61–80 of 1,317 medicines
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + carbidopa + entacapone
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: dexketoprofen
Indicated for: pain and inflammation
Active substance: dexketoprofen
Indicated for: pain and inflammation
Active substance: dexketoprofen
Indicated for: pain and inflammation
Active substance: tadalafil
Indicated for: erectile dysfunction; pulmonary arterial hypertension; benign prostatic hyperplasia
Active substance: tadalafil
Indicated for: erectile dysfunction; pulmonary arterial hypertension; benign prostatic hyperplasia
Active substance: budesonide
Indicated for: asthma; inflammatory bowel disease
Active substance: budesonide
Indicated for: asthma; inflammatory bowel disease
Active substance: terbinafine
D01AE15 Dermatologicals | Antifungals for topical use | Other antifungals for topical use
Indicated for: fungal infections
Active substance: tamsulosin
Indicated for: benign prostatic hyperplasia
Active substance: tafluprost
S01EE05 Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues
Indicated for: glaucoma; ocular hypertension
Active substance: sulfamethoxazole + trimethoprim
Indicated for: bacterial infections
Active substance: osimertinib
Indicated for: non-small cell lung cancer
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.